BIOMARIN PHARMACEUTICAL INC Debt Securities, Available-for-sale
BIOMARIN PHARMACEUTICAL INC (BMRN) had Debt Securities, Available-for-sale of $874.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale $874.00M.
- 2026-03-31: Debt Securities, Available-for-sale $3.07B.
- 2025-12-31: Debt Securities, Available-for-sale $2.05B.
- 2025-09-30: Debt Securities, Available-for-sale $1.99B.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2026-06-30 | $874.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $3.07B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $2.05B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.99B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $1.94B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $1.78B 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $1.66B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.49B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $1.78B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $1.67B 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $1.68B 10-K · filed 2025-02-24 | |
| 2023-09-30 | $1.67B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.56B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $1.49B 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $1.63B 10-K · filed 2024-02-26 | |
| 2022-09-30 | $1.65B 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $1.52B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.52B 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $1.52B 10-K · filed 2023-02-27 | |
| 2021-09-30 | $1.55B 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $1.47B 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $1.41B 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $1.35B 10-K · filed 2022-02-25 | |
| 2020-09-30 | $1.77B 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $1.70B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.15B 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $1.17B 10-K · filed 2021-02-26 | |
| 2019-09-30 | $1.15B 10-Q/A · filed 2019-11-04 | |
| 2019-06-30 | $1.11B 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $1.21B 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $1.32B 10-K · filed 2020-02-27 | |
| 2018-09-30 | $1.65B 10-Q · filed 2018-10-26 | |
| 2017-12-31 | $1.78B 10-K · filed 2019-02-28 | $1.23B 10-K · filed 2018-02-26 |
| 2017-09-30 | $1.24B 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $856.66M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $863.45M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $968.65M 10-K · filed 2018-02-26 | $954.06M 10-K · filed 2017-02-27 |
| 2016-09-30 | $690.46M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $398.94M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $500.80M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $621.23M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $756.37M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $750.52M 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $167.56M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |